Tau, tangles, and Alzheimer's disease
- PMID: 15615640
- DOI: 10.1016/j.bbadis.2004.08.014
Tau, tangles, and Alzheimer's disease
Abstract
Neurofibrillary tangles (NFT) are comprised of the microtubule-associated protein tau, in the form of filamentous aggregates. In addition to the well-known changes in phosphorylation state, tau undergoes multiple truncations and shifts in conformation as it transforms from an unfolded monomer to the structured polymer characteristic of NFT. Truncations at both the amino- and carboxy-termini directly influence the conformation into which the molecule folds, and hence the ability of tau to polymerize into fibrils. Certain of these truncations may be due to cleavage by caspases as part of the apoptotic cascade. In this review, we discuss evidence that strongly suggests that these truncations occur in an orderly pattern and directly influence the ability of tau to polymerize into filaments.
Similar articles
-
MARKing tau for tangles and toxicity.Trends Biochem Sci. 2004 Oct;29(10):548-55. doi: 10.1016/j.tibs.2004.08.001. Trends Biochem Sci. 2004. PMID: 15450610 Review.
-
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.Neurobiol Aging. 2005 Jul;26(7):1015-22. doi: 10.1016/j.neurobiolaging.2004.09.019. Epub 2004 Dec 16. Neurobiol Aging. 2005. PMID: 15748781
-
Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease.J Alzheimers Dis. 2003 Apr;5(2):65-77. doi: 10.3233/jad-2003-5201. J Alzheimers Dis. 2003. PMID: 12719624
-
Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule?Bratisl Lek Listy. 2006;107(9-10):354-8. Bratisl Lek Listy. 2006. PMID: 17262987 Review.
-
Tau pathology in Alzheimer disease and other tauopathies.Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210. doi: 10.1016/j.bbadis.2004.09.008. Biochim Biophys Acta. 2005. PMID: 15615638 Review.
Cited by
-
How Do Retinoids Affect Alzheimer's Disease and Can They Be Novel Drug Candidates?Cureus. 2024 Apr 3;16(4):e57548. doi: 10.7759/cureus.57548. eCollection 2024 Apr. Cureus. 2024. PMID: 38572181 Free PMC article. Review.
-
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.Ann Clin Transl Neurol. 2024 Mar;11(3):673-685. doi: 10.1002/acn3.51988. Epub 2024 Jan 23. Ann Clin Transl Neurol. 2024. PMID: 38263854 Free PMC article.
-
Altered sleep behavior strengthens face validity in the ArcAβ mouse model for Alzheimer's disease.Sci Rep. 2024 Jan 10;14(1):951. doi: 10.1038/s41598-024-51560-3. Sci Rep. 2024. PMID: 38200079 Free PMC article.
-
Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.Acta Neuropathol. 2024 Jan 10;147(1):14. doi: 10.1007/s00401-023-02657-y. Acta Neuropathol. 2024. PMID: 38198008 Free PMC article.
-
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical